Asset Allocation & Management Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,068
Closed -$681K 53
2023
Q2
$681K Hold
3,068
0.27% 36
2023
Q1
$742K Hold
3,068
0.3% 46
2022
Q4
$806K Sell
3,068
-1,165
-28% -$312K 0.31% 46
2022
Q3
$954K Hold
4,233
0.39% 43
2022
Q2
$1.03M Hold
4,233
0.43% 44
2022
Q1
$1.02M Hold
4,233
0.37% 56
2021
Q4
$952K Buy
+4,233
New +$893K 0.32% 66
2020
Q3
Sell
-1,044
Closed -$246K 43
2020
Q2
$246K Sell
1,044
-131
-11% -$29.9K 0.12% 36
2020
Q1
$238K Sell
1,175
-202
-15% -$44.1K 0.12% 46
2019
Q4
$332K Buy
+1,377
New +$304K 0.12% 48

Other funds holding AMGN

Asset Allocation & Management Company's AMGN Position: Q3 2023 in Review

Asset Allocation & Management Company sold out of Amgen (AMGN) in Q3 2023, closing a stake of 3,068 shares — an estimated $681K sold.

Asset Allocation & Management Company first reported a position in AMGN in Q4 2019 and held it in 10 quarters. The position peaked at $1.03M in Q2 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Asset Allocation & Management Company reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Asset Allocation & Management Company sold 3,068 Amgen shares in Q3 2023, an estimated $681K.
  • Asset Allocation & Management Company first reported a position in Amgen in Q4 2019 and held it in 10 quarters.
  • Asset Allocation & Management Company's Amgen position peaked at $1.03M in Q2 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Asset Allocation & Management Company's 13F filing for Q3 2023, filed 17 Oct 2023.